<?xml version='1.0' encoding='utf-8'?>
<document id="23295386"><sentence text="Direct transcriptional regulation of human hepatic cytochrome P450 3A4 (CYP3A4) by peroxisome proliferator-activated receptor alpha (PPARα)." /><sentence text="The nuclear receptor peroxisome proliferator-activated receptor (PPAR)α is known primarily as a regulator of fatty acid metabolism, energy balance, and inflammation, but evidence suggests a wider role in regulating the biotransformation of drugs and other lipophilic chemicals"><entity charOffset="109-119" id="DDI-PubMed.23295386.s2.e0" text="fatty acid" /></sentence><sentence text=" We investigated whether PPARα directly regulates the transcription of cytochrome P450 3A4, the major human drug-metabolizing enzyme" /><sentence text=" Using chromatin immunoprecipitation in human primary hepatocytes as well as electrophoretic mobility shift and luciferase reporter-gene assays, we identified three functional PPARα-binding regions (PBR-I, -II, and -III) within ∼12 kb of the CYP3A4 upstream sequence" /><sentence text=" Furthermore, a humanized CYP3A4/3A7 mouse model showed in vivo induction of CYP3A4 mRNA and protein by [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (WY14,643) in liver but not in intestine, whereas hepatic occupancy of PBRs by PPARα was ligand independent"><entity charOffset="104-160" id="DDI-PubMed.23295386.s5.e0" text="[4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid" /></sentence><sentence text=" Using lentiviral gene knock-down and treatment with WY14,643 in primary human hepatocytes, PPARα was further shown to affect the expression of a distinct set of CYPs, including 1A1, 1A2, 2B6, 2C8, 3A4, and 7A1, but not 2C9, 2C19, 2D6, or 2E1" /><sentence text=" Interestingly, the common phospholipid 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-PC), previously proposed to reflect nutritional status and shown to be a specific endogenous ligand of PPARα, induced CYP3A4 (up to 4-fold) and other biotransformation genes in hepatocytes with similar selectivity and potency as WY14,643" /><sentence text=" These data establish PPARα as a direct transcriptional regulator of hepatic CYP3A4" /><sentence text=" This finding warrants investigation of both known and newly developed PPARα-targeted drugs for their drug-drug interaction potential" /><sentence text=" Furthermore, our data suggest that nutritional status can influence drug biotransformation capacity via endogenous phospholipid signaling" /><sentence text="" /></document>